InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (2 ops.)
Insider track record
OtherDisclosed buys
3
Disclosed sells
2
T+90 hit rate
50%
T+90 mean return
-19.5%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by New Enterprise Associates 16, L.P.. Director active across 7 companies, notably Trevi Therapeutics, Inc.. Aggregated, 8 filings have been recorded. Split: 3 buys · 2 sells. Total volume traded: €6.3m. Activity tracked since 10 December 2021. The latest transaction was filed on 2 October 2025 (X). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to New Enterprise Associates 16, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
189,195 shares@ US$0.01100.0% of flowCommon StockSEC:0001193125-25-232130:0
554,250 shares@ US$3.20100.0% of flowCommon StockSEC:0000950170-24-139630:0
Canonical exit: 23 Mar 2025 (T+90)
2,000,000 shares0Common StockSEC:0001209191-23-037333:0
4,294,207 sharesCommon StockSEC:0001209191-22-059440:0
5,931,843 shares@ €0.0609100.0% of flowCommon StockSEC:0001209191-22-032327:0
2,631,578 shares@ US$1.90100.0% of flowCommon StockSEC:0001209191-22-024301:0
Canonical exit: 10 Jul 2022 (T+90)
37,570 shares@ US$1.321100.0% of flowCommon StockSEC:0001209191-21-071265:0
1,851,852 sharesCommon StockSEC:0001209191-21-061090:0
Canonical exit: 16 Jan 2022 (T+90)
8 of 8 declarations
About New Enterprise Associates 16, L.P.
New Enterprise Associates 16, L.P. is a declarant with 8 filings in total. Across the 8 sampled recent filings from 2021-10-19 to 2025-10-06, the stated amounts are EUR 6,296,426 of buys and EUR 43,946 of sells, and the modal transaction nature is Acquisition. The companies mentioned in these filings include Trevi Therapeutics, Inc., NeueHealth, Inc., Marker Therapeutics, Inc., Mirum Pharmaceuticals, Inc., Akouos, Inc. and Genocea Biosciences, INC., and the listed role for NeueHealth, Inc. is Director.
